Patient-centered medical homes are valuable because they allow insurers to look at the cost of all of the patient’s treatments, services, and physicians throughout the continuum of care, explained Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ.
Patient-centered medical homes are valuable because they allow insurers to look at the cost of all of the patient’s treatments, services, and physicians throughout the continuum of care, explained Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ.
Transcript (slightly modified)
How can innovative programs like patient-centered medical homes improve cancer outcomes and care quality, while managing costs?
So the patient-centered medical home looks at the total cost of care and all the types of services and physicians that a patient may be seeing. Horizon was one of the first in the state of New Jersey, we partnered with the New Jersey American Academy of Family Physicians and 8 primary practices under our healthcare innovations division about 6 years ago to look at a patient-centered medical home model.
Since we were on the forefront with that, we understand that putting those integral pieces together and then looking at the cost along the continuum of care allows for that patient-centered medical home, or patient-centered medical neighborhood, to work. Because you’re bringing everyone together, and you’re looking at all the services that the patient’s having, and all of the physicians that can impact them as they’re going through their care treatments and along that care continuum.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More